Nexstim (NXTMH) Stock Overview
A medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
NXTMH Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Nexstim Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €11.45 |
| 52 Week High | €16.45 |
| 52 Week Low | €6.40 |
| Beta | 0.41 |
| 1 Month Change | -9.49% |
| 3 Month Change | -19.37% |
| 1 Year Change | 30.71% |
| 3 Year Change | 192.46% |
| 5 Year Change | 25.82% |
| Change since IPO | -99.90% |
Recent News & Updates
Revenues Tell The Story For Nexstim Plc (HEL:NXTMH)
Jan 14
Market Participants Recognise Nexstim Plc's (HEL:NXTMH) Revenues Pushing Shares 28% Higher
Oct 15Recent updates
Revenues Tell The Story For Nexstim Plc (HEL:NXTMH)
Jan 14Market Participants Recognise Nexstim Plc's (HEL:NXTMH) Revenues Pushing Shares 28% Higher
Oct 15These 4 Measures Indicate That Nexstim (HEL:NXTMH) Is Using Debt Extensively
Aug 21Calculating The Intrinsic Value Of Nexstim Plc (HEL:NXTMH)
Jul 09Even With A 32% Surge, Cautious Investors Are Not Rewarding Nexstim Plc's (HEL:NXTMH) Performance Completely
Jun 12Here's Why Nexstim (HEL:NXTMH) Can Afford Some Debt
Apr 14Is Now The Time To Look At Buying Nexstim Plc (HEL:NXTMH)?
Nov 17Nexstim's (HEL:NXTMH) Promising Earnings May Rest On Soft Foundations
Aug 20At €4.73, Is Nexstim Plc (HEL:NXTMH) Worth Looking At Closely?
Aug 15Is Nexstim (HEL:NXTMH) A Risky Investment?
Jun 14Nexstim (HEL:NXTMH) Has Debt But No Earnings; Should You Worry?
Dec 02Is Nexstim (HEL:NXTMH) Using Debt In A Risky Way?
Aug 18Shareholder Returns
| NXTMH | FI Medical Equipment | FI Market | |
|---|---|---|---|
| 7D | -4.2% | -10.2% | -0.5% |
| 1Y | 30.7% | -31.2% | 22.1% |
Return vs Industry: NXTMH exceeded the Finnish Medical Equipment industry which returned -31.2% over the past year.
Return vs Market: NXTMH exceeded the Finnish Market which returned 22.1% over the past year.
Price Volatility
| NXTMH volatility | |
|---|---|
| NXTMH Average Weekly Movement | 4.5% |
| Medical Equipment Industry Average Movement | 4.8% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in FI Market | 7.6% |
| 10% least volatile stocks in FI Market | 2.7% |
Stable Share Price: NXTMH has not had significant price volatility in the past 3 months compared to the Finnish market.
Volatility Over Time: NXTMH's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 40 | Mikko Karvinen | www.nexstim.com |
Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company’s transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique whereby pulses of electromagnetic fields target and interact with specific brain regions from outside the head. It provides Navigated Brain Stimulation (NBS) 5 system, a TMS system for the pre-surgical mapping of the motor cortex and the speech areas of the brain; and NBS 6 and NBT, a navigated brain therapy systems for the treatment of major depressive disorder and chronic neuropathic pain.
Nexstim Plc Fundamentals Summary
| NXTMH fundamental statistics | |
|---|---|
| Market cap | €83.31m |
| Earnings (TTM) | -€282.98k |
| Revenue (TTM) | €11.63m |
Is NXTMH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NXTMH income statement (TTM) | |
|---|---|
| Revenue | €11.63m |
| Cost of Revenue | €2.13m |
| Gross Profit | €9.50m |
| Other Expenses | €9.78m |
| Earnings | -€282.98k |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Feb 26, 2026
| Earnings per share (EPS) | -0.039 |
| Gross Margin | 81.66% |
| Net Profit Margin | -2.43% |
| Debt/Equity Ratio | 150.2% |
How did NXTMH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/17 18:20 |
| End of Day Share Price | 2026/02/17 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nexstim Plc is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Antti Siltanen | Inderes Oy |
| Yilmaz Mahshid | Pareto Securities |